The affinity of two antimicrobial peptides derived from bovine milk proteins for model lipid membranes

Colloids and Surfaces A: Physicochemical and Engineering Aspects

Volumn 343, Issue 1-3, 2009, Pages 104-110

  Barzyk, Wanda ^a   Campagna, Sylvie ^b   Wiecław, Katarzyna ^c,d   Korchowiec, Beata ^c,d   Rogalska, Ewa ^d  

^a INSTITUTE OF CATALYSIS AND SURFACE CHEMISTRY   (Poland)

^b UNIVERSITÉ DE LORRAINE   (France)

^c JAGIELLONIAN UNIVERSITY   (Poland)

^d NANCY UNIVERSITÉ   (France)

Author keywords

1,2 Dipalmitoyl sn glycero 3 phospho rac (1 glycerol); 1,2 Dipalmitoyl sn glycero 3 phosphocholine; Langmuir films; Peptide membrane interactions; Phospholipid monolayers

Indexed keywords

AMINES; DRUG INTERACTIONS; GLYCEROL; MOLECULAR DYNAMICS; MONOLAYERS; PEPTIDES; PHASE INTERFACES; PHOSPHOLIPIDS; SURFACE CHEMISTRY;

1,2-DIPALMITOYL-SN-GLYCERO-3-PHOSPHO-RAC-(1-GLYCEROL); 1,2-DIPALMITOYL-SN-GLYCERO-3-PHOSPHOCHOLINE; LANGMUIR FILMS; PEPTIDE-MEMBRANE INTERACTIONS; PHOSPHOLIPID MONOLAYERS;

MEMBRANES;

DIPALMITOYLPHOSPHATIDYLCHOLINE; DIPALMITOYLPHOSPHATIDYLGLYCEROL; L 16 Y; LACTOPHORICIN; MILK PROTEIN; N 23 T; POLYPEPTIDE ANTIBIOTIC AGENT; POLYPEPTIDE ANTIBIOTIC AGENT L 16 Y; UNCLASSIFIED DRUG;

ARTICLE; BACTERIAL MEMBRANE; BINDING AFFINITY; FILM; LIPID MEMBRANE; MEMBRANE MODEL; MEMBRANE POTENTIAL; PRESSURE; PRIORITY JOURNAL; SURFACE PROPERTY;

EID: 67349143369     PISSN: 09277757     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.colsurfa.2009.01.036     Document Type: Article

References (26)

1. Leeb M. A shot in the arm. Nature 431 (2004) 892-893
2. Chambers H.F. The changing epidemiology of Staphylococcus aureus?. Emerg. Infect. Dis. 7 (2001) 178-182
3. Liu Z., Brady A., Young A., Rasimick B., Chen K., Zhou C., and Kallenbach N.R. Length effects in antimicrobial peptides of the (RW)n series. Antimicrob. Agents Chemother. 51 (2007) 597-603
4. Papagianni M. Ribosomally synthesized peptides with antimicrobial properties: biosynthesis, structure, function, and applications. Biotechnol. Adv. 21 (2003) 465-499
5. Sitaram N., and Nagaraj R. Host-defense antimicrobial peptides: importance of structure for activity. Curr. Pharm. Des. 8 (2002) 727-742
6. Dürr U.H.N., Sudheendra U.S., and Ramamoorthy A. LL-37, the only human member of the cathelicidin family of antimicrobial peptides. Biochim. Biophys. Acta 1758 (2006) 1408-1425
7. Brown K.L., and Hancock R.E.W. Cationic host defence (antimicrobial) peptides. Curr. Opin. Immunol. 18 (2006) 24-30
8. Hancock R.E.W., and Rozek A. Role of membranes in the activities of antimicrobial cationic peptides. FEMS Microbiol. Lett. 206 (2002) 143-149
9. Dhople V., Krukemeyer A., and Ramamoorthy A. The human beta-defensin-3, an antibacterial peptide with multiple biological functions. Biochim. Biophys. Acta 1758 (2006) 1499-1512
10. Campagna S., Mathot A.G., Fleury Y., Girardet J.M., and Gaillard J.L. Antibacterial activity of lactophoricin, a synthetic 23-residues peptide derived from the sequence of bovine milk component-3 of proteose peptone. J. Dairy Sci. 87 (2004) 1621-1626
11. Campagna S., Cosette P., Molle G., and Gaillard J.L. Evidence for membrane affinity of the C-terminal domain of bovine milk PP3 component. Biochim. Biophys. Acta 1513 (2001) 217-222
12. Recio S., and Visser S. Identification of two distinct antibacterial domains within the sequence of bovine alpha(s2)-casein. Biochim. Biophys. Acta 1428 (1999) 314-326
13. Hoagland P.D., Unruh J.J., Wickham E.D., and Farrell Jr. H.M. Secondary structure of bovine α-S2-casein: theoretical and experimental approaches. J. Dairy Sci. 84 (2001) 1944-1949
14. Yeaman M.R., and Yount N.Y. Mechanisms of antimicrobial peptide action and resistance. Pharmacol. Rev. 55 (2003) 27-55
15. Brockman H. Lipid monolayers: why use half a membrane to characterize protein-membrane interactions?. Curr. Opin. Struct. Biol. 9 (1999) 438-443
16. Volinsky R., Kolusheva S., Berman A., and Jelinek R. Investigations of antimicrobial peptides in planar film systems. Biochim. Biophys. Acta 1758 (2006) 1393-1407
17. Brezesinski G., and Möhwald H. Langmuir monolayers to study interactions at model membrane surfaces. Adv. Colloid Interface Sci. 100-102 (2003) 563-584
18. Blume A. A comparative study of the phase transitions of phospholipid bilayers and monolayers. Biochim. Biophys. Acta 557 (1979) 32-44
19. Corvis Y., Barzyk W., Brezesinski G., Mrabet N., Badis M., Hecht S., and Rogalska E. Interactions of a fungistatic antibiotic, griseofulvin, with phospholipid monolayers used as models of biological membranes. Langmuir 22 (2006) 7701-7711
20. Korchowiec B., Corvis Y., Viitala T., Feidt C., Guiavarch Y., Corbier C., and Rogalska E. Interfacial approach to polyaromatic hydrocarbon toxicity: phosphoglyceride and cholesterol monolayer response to phenantrene, anthracene, pyrene, chrysene and benzo[a]pyrene. J. Phys. Chem. B 112 (2008) 13518-13531
21. Olak C., Muenter A., Andrae J., and Brezesinski G. Interfacial properties and structural analysis of the antimicrobial peptide NK-2. J. Pept. Sci. 14 (2008) 510-517
22. Davies J.T., and Rideal E.K. Interfacial Phenomena. 2nd ed. (1963), Academic Press, New York-London
23. Shai Y. Mechanism of the binding, insertion and destabilization of phospholipid bilayer membranes by α-helical antimicrobial and cell non-selective membrane-lytic peptides. Biochim. Biophys. Acta 1462 (1999) 55-70
24. Papo N., and Shai Y. Can we predict biological activity of antimicrobial peptides from their interactions with model phospholipid membranes?. Peptides 24 (2003) 1693-1703
25. Sitaram N., and Nagaraj R. Interaction of antimicrobial peptides with biological and model membranes: structural and charge requirements for activity. Biochim. Biophys. Acta 1462 (1999) 29-54
26. Campagna S., Mau N.V., Heitz F., Humbert G., and Gaillard J.L. Specific interaction between anionic phospholipids and milk bovine component PP3 and its 119-135 C-terminal fragment. Colloids Surf. B: Biointerf. 13 (1999) 299-309